FIELD: medicine.
SUBSTANCE: invention relates to efferent medicine and can be used in case of necessity of extracorporal blood purification in patients with purulent-septic conditions. For this purpose perfusion of blood through column with sorbent is performed. As sorbent Strosorb 414, or stirosorb 514, or Stirosorb 516 is used.
EFFECT: method makes it possible to increase efficiency of said pathology treatment due to selection of specified sorbents, which ensure binding of not only excessive number of endogenic mediators inducing development of pathophysiological disorders, resulting in development of organ and poly-organ failure, but also exogenic trigger and mediator inflammation factors, such as lipopolysaccharides and colony-forming cells.
2 cl, 2 tbl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
USE OF SORBENT GRANULES FROM SUPER-CROSS-LINKED POLYSTYRENE "STIROSORB 516" AS A CONTACT HEMOACTIVATOR OF BLOOD CELL ELEMENTS | 2019 |
|
RU2712630C1 |
METHOD OF OBTAINING DEPOSITED LYMPHOKINE-ACTIVATED KILLER CELLS | 2009 |
|
RU2400238C1 |
METHOD FOR PRODUCING ACTIVATED LEUKOCYTES FOR ADJUVANT ADOPTIVE IMMUNOTHERAPY OF MALIGNANT GROWTHS | 2009 |
|
RU2414915C2 |
AGENT FOR REDUCING SYSTEMIC PATHOLOGIC ENDOTOXINEMIA | 2014 |
|
RU2564918C1 |
METHOD FOR PREPARING ACTIVATED MONONUCLEAR LEUKOCYTES | 2009 |
|
RU2402338C1 |
METHOD OF DIAGNOSTICS OF ORGANISM SYSTEM INFLAMMATORY RESPONSE FOR CRITICAL STATES | 2007 |
|
RU2328219C1 |
METHOD FOR PREPARING 1-HEXADECYL-R-(-)-3-HYDROXY-1-AZONIABICYCLO[2.2.2]OCTANE BROMIDE - IMMUNOMODULATOR ELICITING ANTITUMOR, BACTERIOSTATIC AND ANTI-AGGREGATIVE PROPERTIES | 2005 |
|
RU2321589C2 |
ANTIBACTERIAL PEPTIDES | 2007 |
|
RU2468033C2 |
1-HEXADECYL-R-(-)-3-OXY-1-AZONIABICYCLO[2.2.2]OCTANE BROMIDE AS IMMUNOMODULATOR WITH ANTITUMOR, BACTERIOSTATIC AND ANTI-AGGREGATION PROPERTIES AND METHOD FOR ITS PREPARING | 2005 |
|
RU2296761C2 |
METHOD FOR STERILIZATION OF ULTRAHIGH MOLECULAR POLYETHYLENE, INTENDED FOR USE IN MEDICINE (VERSIONS) | 2015 |
|
RU2603477C1 |
Authors
Dates
2012-04-27—Published
2010-09-20—Filed